How is the efficacy of patient selection criteria for adjuvant pembrolizumab after curative surgical treatment of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience

ERDEM S., TANTEKİN S. A., ÖZERVARLI M. F., ERGÜL R. B., PAZIR Y., HÜRDOĞAN Ö., ...More

16th European Multidisciplinary Congress on Urological Cancers (EMUC) 2024, Lizbon, Portugal, 7 - 10 November 2024, pp.262-263, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • City: Lizbon
  • Country: Portugal
  • Page Numbers: pp.262-263
  • Istanbul University Affiliated: Yes